The AI landscape doesn't move in one direction — it lurches. Some techniques leap from experiment to table stakes in a single quarter; others stall against regulatory walls, technical ceilings, or organisational inertia that no amount of hype can dislodge. Knowing which is which is the hard part. The State of Play cuts through the noise with a rigorously maintained index of AI techniques across every major business domain — classified by maturity, evidenced by real-world adoption, and updated daily so you always know where you stand relative to the field. Stop guessing. Start knowing.
A daily newsletter distilling the past two weeks of movement in a domain or two — delivered to your inbox while the index updates in the background.
Each dot marks the weighted maturity of practices within a domain — hover for a brief summary, click for more detail
AI that scores customer health, detects churn signals, and triggers proactive intervention workflows. Includes usage-based health scoring and early warning systems; distinct from customer journey analysis which maps experience rather than predicting outcomes.
Customer health scoring and churn prediction has matured into a proven capability with GA tooling, documented ROI, and a deep evidence base — yet a persistent gap between technical readiness and execution quality defines the practice today. The underlying problem is well understood: customer success teams need both a prioritisation signal (which accounts need attention now) and a forecasting signal (which accounts will churn). Vendor platforms from Gainsight, ChurnZero, Salesforce, and Microsoft now ship both capabilities as standard features, and peer-reviewed research across 200+ studies confirms ensemble ML models routinely achieve 89-97% prediction accuracy in production. The question is no longer whether the technology works. It is whether organisations can implement it well enough to realise the 15-25% churn reductions that top deployments demonstrate. Most cannot: subjective score weighting, poor data integration, and insufficient calibration mean the majority of deployed health scores underperform simple churn-rate baselines. For enterprises with clean data pipelines, the practice delivers measurable retention and net-revenue impact. For everyone else, the rollout challenge — not the technology — remains the constraint.
Gainsight's Staircase AI Health Score, generally available since early 2026, represents the current state of the art: real-time 0-100 scoring that blends sentiment analysis, engagement patterns, and response-time signals with customisable weighting. ChurnZero offers structured health scores mapped to specific churn archetypes, while Salesforce Einstein and Microsoft Dynamics 365 Customer Insights provide embedded prediction engines with automated model retraining. Microsoft's Fabric platform surfaces production-ready tutorials on churn modeling using gradient-boosted trees, demonstrating democratization of technical implementation. The vendor ecosystem is feature-complete and mature. Deployment results at well-resourced organisations are compelling: a mid-market B2B SaaS company reduced first-year churn from 34% to 11%, increased NRR from 96% to 118%, and attributed $8.4M in retained and expanded revenue to unified health scoring with automated interventions; Waystar deployed ChurnZero and achieved 20% churn reduction. A feedback-driven approach using AI analysis of support tickets and survey data achieved a 56% churn reduction (8% to 3.5% monthly) by identifying behavioral patterns and triggering psychological interventions. A systematic review of 142 studies found predictive health scoring achieving 89%+ accuracy with 34-47% NRR improvements in production settings. G2 survey data across platforms documents 15-25% churn reductions (Chargebee up to 25%, Velaris averaging 15%). The global AI-enhanced churn scoring market reached $2.53B in 2025 and is projected to grow 24.5% annually to $3.15B in 2026 and $7.48B by 2030.
The execution gap remains significant, however. Eighty percent of customer success teams remain experimental with AI-driven scoring despite years of vendor investment. Year 1 total cost of ownership runs $60K-$99K for ChurnZero to $90K-$140K for Gainsight, with realistic setup demanding 150+ hours and specialist resources for ongoing calibration. Practitioner assessments reveal that most deployed scores fail to outperform churn-rate baselines — a consequence of subjective weighting and poor signal selection that erodes CSM trust through persistent false positives. Critical implementation analysis shows that 83% precision models fail in production because prediction capability does not automatically translate to intervention execution; deployment gaps include cold-start reliability issues (models unreliable on customers under 14-30 days old), prediction-window mismatches (30-day models surface signals too late for multi-touch retention campaigns), and silent model drift requiring frequent retraining cycles. TSIA analysts warn that many health-scoring pilots lack ROI visibility, and disconnected data systems remain the primary blocking constraint. The practice delivers proven value at enterprise scale but has stalled at the boundary of mid-market adoption, where cost, complexity, and data quality challenges compound.
— Comprehensive churn metrics framework: logo churn, revenue churn, NRR calculations, and health score construction. Details leading vs. lagging indicators; health scores as proactive intervention signal; 15 documented churn-reduction strategies.
— 8-platform comparison emphasizing signal quality (behavioral data earliest indicator), prediction methods (ML models vs configurable scoring), and activation strategies. Highlights prediction-to-action workflow as differentiator.
— Peer-reviewed research: XGBoost achieved 93.97% accuracy and 0.98 AUC on telecom dataset. Demonstrates practical integration of churn prediction with behavioral segmentation enabling differentiated retention strategies by customer segment.
— Market sizing: $1.62B (2025) to $10.74B (2036), 19% CAGR. SaaS platforms 61.4% revenue. Churn prediction/retention 37.2% of use cases. Large enterprises 64.8% adoption. Confirms ecosystem maturity and vendor consolidation.
— GA platform with AI health scoring and churn prediction. Vendor-reported outcomes: 60% churn reduction, 65% onboarding improvement, 21% GRR increase, 2x CLV improvement; demonstrates platform feature maturity and ROI potential.
— Critical assessment documenting intervention failures: accurate model (70%+ risk) yielded no better retention than unflagged accounts. Identifies three gaps: scores lack causal drivers, models ignore 80-90% enterprise unstructured data, no actionable next-step guidance.
— Critical analysis: typical health score accuracy ~85%; composite scores (4+ dimensions) show 34% better accuracy. Identifies specific churn signals (usage drop 20% over 90 days, support escalation 30%+, exec champion departure 51-65% risk). CSM data fragmentation barrier.
— Multi-year deployment framework with specific outcomes: 7% renewal lift, 15% accuracy improvement via monthly recalibration, 3% fraud reduction. Insurance survey: 64% of leaders view dynamic scoring as critical competitive advantage.